Document:

Third, Fourth and Fifth Amendments to the Sales Agent Agreement

 Exhibit 10.8 
  
 AMENDMENT NO. 3 TO SALES AGENT AGREEMENT 
  
 This Amendment No. 3 To Sales Agent Agreement (“Amendment”) is made this 3rd day of May, 2004, between Cutera, Inc. (formerly Altus Medical, Inc.) (“Cutera”) and PSS World Medical, Inc. (“PSS”). 

 
 WHEREAS, Cutera and PSS entered into that February 14, 2003 Sales Agent
Agreement, that March 17, 2003 Amendment No. 1 To Sales Agent Agreement, and that November 6, 2003 Amendment No. 2 To Sales Agent Agreement (collectively, “Agreement”), and are hereby amending the Agreement as follows: 
  
 1. The first sentence of Section 1.4 is hereby deleted and replaced with the following:

  
 “1.4 Products means Cutera’s CoolGlide CV-,
CoolGlide Excel-, CoolGlide Vantage-, CoolGlide Genesis-, CoolGlide Genesis Plus-, CoolGlide Xeo-, CoolGlide Xeo Limited-, and Xeo SA systems.” 
  
 2. Exhibit A is hereby deleted and replaced with the following: 
  
 “Product Pricing 
  
 For Products sold to PSS from April 1, 2004 until September 30, 2004, the unit pricing will be as set forth below. The pricing for Products sold after
September 30, 2004 will be negotiated by the parties in good faith at least two months before that date. All Product pricing information will be deemed Cutera’s Confidential Information. 
  

				
	 Product

	  	Unit Price

	 CoolGlide CV
	  	$	[****]  
	 CoolGlide Genesis
	  	$	[****]  
	 Xeo SA
	  	$	[****]  
	 CoolGlide Excel
	  	$	[****]  
	 CoolGlide Genesis Plus
	  	$	[****]  
	 CoolGlide Vantage
	  	$	[****]  
	 CoolGlide Xeo Limited
	  	$	[****]  
	 CoolGlide Xeo
	  	$	[****]”

  
 The capitalized terms that are used,
but not defined, in this Amendment shall have the same definitions provided in the Agreement. Except as expressly stated in this Amendment, the Agreement shall remain unmodified and in full force and effect. 
  

							
	 Cutera, Inc.
	 	 PSS World Medical, Inc.

				
	By:	 	 /s/ Kevin Connors

	 	By:	  	 /s/ Robert P. Gibson

	Printed:	 	Kevin Connors	 	Printed:	  	Robert P. Gibson II
	Its:	 	President & CEO	 	Its:	  	V.P. Marketing

  
  
 **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 
  

 1 

 AMENDMENT NO. 4 TO SALES AGENT AGREEMENT 
  
 This Amendment No. 4 To Sales Agent Agreement (“Amendment No. 4”) is made this
18th day of June, 2004, between Cutera Inc. (formerly Altus Medical, Inc.) (“Cutera”) and PSS World
Medical, Inc. (“PSS”). 
  
 WHEREAS, Cutera and PSS entered into that
February 14, 2003 Sales Agent Agreement, that March 17, 2003 Amendment No. 1 To Sales Agent Agreement, that November 6, 2003 Amendment No. 2 To Sales Agent Agreement, and that May 3, 2004 Amendment No. 3 To Sales Agent Agreement (collectively,
“Agreement”), and are hereby amending the Agreement as follows: 
  
 1.
Cutera will from time to time provide PSS with lists of “Altus Prospects,” as contemplated in section 3.2 of the Agreement. PSS agrees that: (i) these lists, and the identities of Altus Prospects, constitute Cutera’s Confidential
Information, as defined in section 9.3 of the Agreement; (ii) PSS will use this information only in furtherance of the Agreement and will not disclose such information to any third parties; and, (iii) only Jim Garibaldi of PSS will view these lists,
and will not disclose their contents to any other person at PSS, except only to the PSS sales employees that he manages, and only such sections thereof that are necessary to permit each such sales employee to help close sales of Cutera’s
products pursuant to the Agreement. 
  
 2. The capitalized terms that are used,
but not defined, in this Amendment No. 4 shall have the same definitions provided in the Agreement. Except as expressly stated in this Amendment No. 4, the Agreement shall remain unmodified and in full force and effect. 
  

							
	 Cutera, Inc.
	 	 PSS World Medical, Inc.

				
	 By:
	  	 /s/ Ronald J. Santilli

	 	 By:
	 	 /s/ Robert P. Gibson

	 Printed:
	  	 Ronald J. Santilli
	 	 Printed:
	 	 Robert P. Gibson II

	 Its:
	  	 V.P. and CFO
	 	 Its:
	 	 V.P. Marketing

 AMENDMENT NO. 5 TO SALES AGENT AGREEMENT 
  
 This Amendment No. 5 To Sales Agent Agreement (“Amendment No. 5”) is made this
21st day of September, 2004, between Cutera Inc. (formerly Altus Medical, Inc.) (“Cutera”) and PSS World
Medical, Inc. (“PSS”). 
  
 WHEREAS, Cutera and PSS entered into that
February 14, 2003 Sales Agent Agreement, that March 17, 2003 Amendment No. 1 To Sales Agent Agreement, that November 6, 2003 Amendment No. 2 To Sales Agent Agreement, that May 3, 2004 Amendment No. 3 To Sales Agent Agreement and that June 18, 2004
Amendment No. 4 to Sales Agent Agreement (collectively, “Agreement”), and are hereby amending the Agreement as follows: 
  
 1. The first sentence of Section 1.4 is hereby deleted and replaced with the following: 
  
 “1.4 Products means Cutera’s CoolGlide CV-, CoolGlide Excel-, CoolGlide Vantage-, CoolGlide Genesis Plus-,
CoolGlide Xeo-, CoolGlide Xeo Limited-, and Xeo SA systems.” 
  
 2. Exhibit A
is hereby deleted and replaced with the following: 
  
 “Product Pricing 
  
 For Products sold to
PSS from October 1, 2004 until March 31, 2005, the unit pricing will be as set forth below. The pricing for Products sold after March 31, 2005 will be negotiated by the parties in good faith at least two months before that date. All Product pricing
information will be deemed Cutera’s Confidential Information. 
  

					
	 Product

	  	Unit
Price

	 
	 CoolGlide CV
	  	$	[****]	 
	 Xeo SA – w/ LP560 or OPS600
	  	$	[****]	 
	 Xeo SA – w/ Titan
	  	$	[****]	 
	 Xeo SA – w/ Titan, plus LP560 or OPS600
	  	$	[****]	 
	 CoolGlide Excel
	  	$	[****]	 
	 CoolGlide Genesis Plus
	  	$	[****]	 
	 CoolGlide Vantage
	  	$	[****]	 
	 CoolGlide Xeo Limited
	  	$	[****]	 
	 CoolGlide Xeo – w/ LP560 or OPS600
	  	$	[****]	 
	 CoolGlide Xeo – w/ Titan, plus LP560 or OPS600
	  	$	[****]	”

  
 2. The capitalized terms that are
used, but not defined, in this Amendment No. 5 shall have the same definitions provided in the Agreement. Except as expressly stated in this Amendment No. 5, the Agreement shall remain unmodified and in full force and effect. 
  

							
	 Cutera, Inc.
	 	 PSS World Medical, Inc.

				
	 By:
	 	 /s/ Ronald J. Santilli

	 	 By:
	 	 /s/ Robert P. Gibson

	 Printed:
	 	 Ronald J. Santilli
	 	 Printed:
	 	 Robert P. Gibson II

	 Its:
	 	 V.P. and CFO
	 	 Its:
	 	 V.P. Marketing

  
  
 **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions.Employee Stock Purchase Plan, as amended October 14, 2004

 Exhibit 10.1 
  
 

 
  
 SIRENZA MICRODEVICES, INC.

  
 2000 EMPLOYEE STOCK PURCHASE PLAN 
  
 As amended on October 14, 2004 
  
 The following constitute the provisions of the 2000 Employee Stock Purchase
Plan of Sirenza Microdevices, Inc. 
  
 1. Purpose. The
purpose of the Plan is to provide employees of the Company and its Designated Subsidiaries with an opportunity to purchase Common Stock of the Company through accumulated payroll deductions. It is the intention of the Company to have the Plan
qualify as an “Employee Stock Purchase Plan” under Section 423 of the Internal Revenue Code of 1986, as amended. The provisions of the Plan, accordingly, shall be construed so as to extend and limit participation in a manner consistent
with the requirements of that section of the Code. 
  
 2.
Definitions. 
  
 (a)
“Board” shall mean the Board of Directors of the Company or any committee thereof designated by the Board of Directors of the Company in accordance with Section 14 of the Plan. 
  
 (b) “Code” shall mean the Internal Revenue
Code of 1986, as amended. 
  
 (c) “Common
Stock” shall mean the common stock of the Company. 
  
 (d) “Company” shall mean Sirenza Microdevices, Inc. and any Designated Subsidiary of the Company. 
  
 (e) “Compensation” shall mean all base straight time gross earnings and overtime, but exclusive of payments for shift
premium, incentive compensation, incentive payments, bonuses, commissions and other compensation. 
  
 (f) “Designated Subsidiary” shall mean any Subsidiary that has been designated by the Board from time to time in its sole
discretion as eligible to participate in the Plan. 
  
 (g) “Employee” shall mean any individual who is an Employee of the Company for tax purposes whose customary employment with the Company is at least twenty (20) hours per week and more than five (5) months in any calendar
year. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on sick leave or other leave of absence approved by the Company. Where the period of leave exceeds 90 days and the
individual’s right to reemployment is not guaranteed either by statute or by contract, the employment relationship shall be deemed to have terminated on the 91st day of such leave. 

 (h) “Enrollment Date” shall mean the first Trading Day of each Offering
Period. 
  
 (i) “Exercise Date”
shall mean the first Trading Day on or after May 15 and November 15 of each year. 
  
 (j) “Fair Market Value” shall mean, as of any date, the value of Common Stock determined as follows: 
  
 (i) If the Common Stock is listed on any established stock
exchange or a national market system, including without limitation the Nasdaq National Market or The Nasdaq SmallCap Market of The Nasdaq Stock Market, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no
sales were reported) as quoted on such exchange or system for the last market trading day prior to the date of determination, as reported in The Wall Street Journal or such other source as the Board deems reliable; 
  
 (ii) If the Common Stock is regularly quoted by a recognized
securities dealer but selling prices are not reported, its Fair Market Value shall be the mean of the closing bid and asked prices for the Common Stock for the last market trading day prior to the date of determination, as reported in The Wall
Street Journal or such other source as the Board deems reliable; 
  
 (iii) In the absence of an established market for the Common Stock, the Fair Market Value thereof shall be determined in good faith by the Board; or 
  
 (iv) For purposes of the Enrollment Date of the first Offering Period under the Plan, the Fair Market Value
shall be the initial price to the public as set forth in the final prospectus included within the registration statement in Form S-1 filed with the Securities and Exchange Commission for the initial public offering of the Company’s Common Stock
(the “Registration Statement”). 
  
 (k)
“Offering Periods” shall mean (i) for all periods commencing prior to November 15, 2004, the periods of approximately twenty-four (24) months during which an option granted pursuant to the Plan may be exercised, commencing on the
first Trading Day on or after May 15 and November 15 of each year and terminating on the first Trading Day on or after the May 15 or November 15 Offering Period commencement date approximately twenty-four months later; provided, however, that the
first Offering Period under the Plan shall commence on May 24, 2000 and end on the first Trading Day on or after May 15, 2002 and the second Offering Period under the Plan shall commence on the first Trading Day on or after November 15, 2000; or
(ii) for all periods commencing on or after November 15, 2004, the periods of approximately twelve (12) months during which an option granted pursuant to the Plan may be exercised, commencing on the first Trading Day on or after May 15 and November
15 of each year and terminating on the first Trading Day on or after the May 15 or November 15 Offering Period commencement date approximately twelve months later. The duration and timing of Offering Periods may be changed pursuant to Section 4 of
this Plan. 
  

 -2- 

 (l) “Plan” shall mean this 2000 Employee Stock Purchase Plan.

  
 (m) “Purchase Period” shall
mean the approximately six month period commencing on one Exercise Date and ending with the next Exercise Date, except that the first Purchase Period of any Offering Period shall commence on the Enrollment Date and end with the next Exercise Date.

  
 (n) “Purchase Price” shall
mean 85% of the Fair Market Value of a share of Common Stock on the Enrollment Date or on the Exercise Date, whichever is lower; provided however, that the Purchase Price may be adjusted by the Board pursuant to Section 20. 
  
 (o) “Reserves” shall mean the number of
shares of Common Stock covered by each option under the Plan which have not yet been exercised and the number of shares of Common Stock which have been authorized for issuance under the Plan but not yet placed under option. 
  
 (p) “Subsidiary” shall mean a corporation,
domestic or foreign, of which not less than 50% of the voting shares are held by the Company or a Subsidiary, whether or not such corporation now exists or is hereafter organized or acquired by the Company or a Subsidiary. 
  
 (q) “Trading Day” shall mean a day on which
national stock exchanges and the Nasdaq System are open for trading. 
  
 3. Eligibility. 
  
 (a) Any
Employee who shall be employed by the Company on a given Enrollment Date shall be eligible to participate in the Plan. 
  
 (b) Any provisions of the Plan to the contrary notwithstanding, no Employee shall be granted an option under the Plan (i) to the extent
that, immediately after the grant, such Employee (or any other person whose stock would be attributed to such Employee pursuant to Section 424(d) of the Code) would own capital stock of the Company and/or hold outstanding options to purchase such
stock possessing five percent (5%) or more of the total combined voting power or value of all classes of the capital stock of the Company or of any Subsidiary, or (ii) to the extent that his or her rights to purchase stock under all employee stock
purchase plans of the Company and its subsidiaries accrues at a rate which exceeds Twenty-Five Thousand Dollars ($25,000) worth of stock (determined at the fair market value of the shares at the time such option is granted) for each calendar year in
which such option is outstanding at any time. 
  
 4. Offering
Periods. The Plan shall be implemented by consecutive and sometimes overlapping Offering Periods with a new Offering Period commencing on the first Trading Day on or after May 15 and November 15 each year, or on such other date as the Board
shall determine, and continuing thereafter until terminated in accordance with Section 20 hereof. The Board shall have the power to change the duration of Offering Periods (including the commencement dates thereof) with respect to future offerings
without shareholder approval if such change is announced at least five (5) days prior to the scheduled beginning of the first Offering Period to be affected thereafter. 
  

 -3- 

 5. Participation. 
  
 (a) An eligible Employee may become a participant in the Plan by completing a subscription agreement
authorizing payroll deductions in the form of Exhibit A to this Plan and filing it with the Company’s payroll office prior to the applicable Enrollment Date. 
  
 (b) Payroll deductions for a participant shall commence on the first payroll following the Enrollment Date
and shall end on the last payroll in the Offering Period to which such authorization is applicable, unless sooner terminated by the participant as provided in Section 10 hereof. 
  
 6. Payroll Deductions. 
  
 (a) At the time a participant files his or her subscription agreement, he or she shall elect to have payroll deductions made on each pay
day during the Offering Period in an amount not exceeding fifteen percent (15%) of the Compensation which he or she receives on each pay day during the Offering Period. 
  
 (b) All payroll deductions made for a participant shall be credited to his or her account under the Plan and
shall be withheld in whole percentages only. A participant may not make any additional payments into such account. 
  
 (c) A participant may discontinue his or her participation in the Plan as provided in Section 10 hereof, or may increase or decrease the
rate of his or her payroll deductions during the Offering Period by completing or filing with the Company a new subscription agreement authorizing a change in payroll deduction rate. The Board may, in its discretion, limit the number of
participation rate changes during any Offering Period. The change in rate shall be effective with the first full payroll period following five (5) business days after the Company’s receipt of the new subscription agreement unless the Company
elects to process a given change in participation more quickly. A participant’s subscription agreement shall remain in effect for successive Offering Periods unless terminated as provided in Section 10 hereof. 
  
 (d) Notwithstanding the foregoing, to the extent necessary
to comply with Section 423(b)(8) of the Code and Section 3(b) hereof, a participant’s payroll deductions may be decreased to zero percent (0%) at any time during a Purchase Period. Payroll deductions shall recommence at the rate provided in
such participant’s subscription agreement at the beginning of the first Purchase Period which is scheduled to end in the following calendar year, unless terminated by the participant as provided in Section 10 hereof. 
  
 (e) At the time the option is exercised, in whole or in
part, or at the time some or all of the Company’s Common Stock issued under the Plan is disposed of, the participant must make adequate provision for the Company’s federal, state, or other tax withholding obligations, if any, which arise
upon the exercise of the option or the disposition of the Common Stock. At any time, the Company may, but shall not be obligated to, withhold from the participant’s compensation the amount necessary for the Company to meet applicable
withholding obligations, including any withholding required to make available to the Company any tax deductions or benefits attributable to sale or early disposition of Common Stock by the Employee. 
  

 -4- 

 7. Grant of Option. On the Enrollment Date of each Offering Period, each eligible Employee
participating in such Offering Period shall be granted an option to purchase on each Exercise Date during such Offering Period (at the applicable Purchase Price) up to a number of shares of the Company’s Common Stock determined by dividing such
Employee’s payroll deductions accumulated prior to such Exercise Date and retained in the Participant’s account as of the Exercise Date by the applicable Purchase Price; provided that in no event shall an Employee be permitted to purchase
during each Purchase Period more than 10,000 shares of the Company’s Common Stock (subject to any adjustment pursuant to Section 19), and provided further that such purchase shall be subject to the limitations set forth in Sections 3(b) and 12
hereof. The Board may, for future Offering Periods, increase or decrease, in its absolute discretion, the maximum number of shares of the Company’s Common Stock an Employee may purchase during each Purchase Period of such Offering Period.
Exercise of the option shall occur as provided in Section 8 hereof, unless the participant has withdrawn pursuant to Section 10 hereof. The option shall expire on the last day of the Offering Period. 
  
 8. Exercise of Option. 
  
 (a) Unless a participant withdraws from the Plan as provided
in Section 10 hereof, his or her option for the purchase of shares shall be exercised automatically on the Exercise Date, and the maximum number of full shares subject to option shall be purchased for such participant at the applicable Purchase
Price with the accumulated payroll deductions in his or her account. No fractional shares shall be purchased; any payroll deductions accumulated in a participant’s account which are not sufficient to purchase a full share shall be retained in
the participant’s account for the subsequent Purchase Period or Offering Period, subject to earlier withdrawal by the participant as provided in Section 10 hereof. Any other monies left over in a participant’s account after the Exercise
Date shall be returned to the participant. During a participant’s lifetime, a participant’s option to purchase shares hereunder is exercisable only by him or her. 
  
 (b) If the Board determines that, on a given Exercise Date, the number of shares with respect to which
options are to be exercised may exceed (i) the number of shares of Common Stock that were available for sale under the Plan on the Enrollment Date of the applicable Offering Period, or (ii) the number of shares available for sale under the Plan on
such Exercise Date, the Board may in its sole discretion (x) provide that the Company shall make a pro rata allocation of the shares of Common Stock available for purchase on such Enrollment Date or Exercise Date, as applicable, in as uniform a
manner as shall be practicable and as it shall determine in its sole discretion to be equitable among all participants exercising options to purchase Common Stock on such Exercise Date, and continue all Offering Periods then in effect, or (y)
provide that the Company shall make a pro rata allocation of the shares available for purchase on such Enrollment Date or Exercise Date, as applicable, in as uniform a manner as shall be practicable and as it shall determine in its sole discretion
to be equitable among all participants exercising options to purchase Common Stock on such Exercise Date, and terminate any or all Offering Periods then in effect pursuant to Section 20 hereof. The Company may make pro rata allocation of the shares
available on the Enrollment Date of any applicable Offering Period pursuant to the preceding sentence, notwithstanding any authorization of additional shares for issuance under the Plan by the Company’s shareholders subsequent to such
Enrollment Date. 
  

 -5- 

 9. Delivery. As promptly as practicable after each Exercise Date on which a purchase of shares
occurs, the Company shall arrange the delivery to each participant, as appropriate, of a certificate representing the shares purchased upon exercise of his or her option. 
  
 10. Withdrawal. 
  
 (a) A participant may withdraw all but not less than all the payroll deductions credited to his or her account and not yet used to
exercise his or her option under the Plan at any time by giving written notice to the Company in the form of Exhibit B to this Plan. All of the participant’s payroll deductions credited to his or her account shall be paid to such participant
promptly after receipt of notice of withdrawal and such participant’s option for the Offering Period shall be automatically terminated, and no further payroll deductions for the purchase of shares shall be made for such Offering Period. If a
participant withdraws from an Offering Period, payroll deductions shall not resume at the beginning of the succeeding Offering Period unless the participant delivers to the Company a new subscription agreement. 
  
 (b) A participant’s withdrawal from an Offering Period
shall not have any effect upon his or her eligibility to participate in any similar plan which may hereafter be adopted by the Company or in succeeding Offering Periods which commence after the termination of the Offering Period from which the
participant withdraws. 
  
 11. Termination of Employment.

  
 Upon a participant’s ceasing to be an
Employee, for any reason, he or she shall be deemed to have elected to withdraw from the Plan and the payroll deductions credited to such participant’s account during the Offering Period but not yet used to exercise the option shall be returned
to such participant or, in the case of his or her death, to the person or persons entitled thereto under Section 15 hereof, and such participant’s option shall be automatically terminated. The preceding sentence notwithstanding, a participant
who receives payment in lieu of notice of termination of employment shall be treated as continuing to be an Employee for the participant’s customary number of hours per week of employment during the period in which the participant is subject to
such payment in lieu of notice. 
  
 12. Interest. No
interest shall accrue on the payroll deductions of a participant in the Plan. 
  
 13. Stock. 
  
 (a) Subject to adjustment upon changes in capitalization of the Company as provided in Section 19 hereof, the maximum number of shares of the Company’s Common Stock which shall be made available for sale under the Plan shall be 300,000
shares plus an annual increase to be added on the first day of the Company’s fiscal year beginning in 2001, equal to the lesser of (i) 350,000 shares, (ii) 1% of the outstanding shares on such date or (iii) a lesser amount determined by the
Board. 
  
 (b) The participant shall have no
interest or voting right in shares covered by his option until such option has been exercised. 
  
 (c) Shares to be delivered to a participant under the Plan shall be registered in the name of the participant or in the name of the
participant and his or her spouse. 
  

 -6- 

 14. Administration. The Plan shall be administered by the Board or a committee of members of the
Board appointed by the Board. The Board or its committee shall have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, to determine eligibility and to adjudicate all disputed claims filed under the
Plan. Every finding, decision and determination made by the Board or its committee shall, to the full extent permitted by law, be final and binding upon all parties. 
  
 15. Designation of Beneficiary. 
  
 (a) A participant may file a written designation of a beneficiary who is to receive any shares and cash, if
any, from the participant’s account under the Plan in the event of such participant’s death subsequent to an Exercise Date on which the option is exercised but prior to delivery to such participant of such shares and cash. In addition, a
participant may file a written designation of a beneficiary who is to receive any cash from the participant’s account under the Plan in the event of such participant’s death prior to exercise of the option. If a participant is married and
the designated beneficiary is not the spouse, spousal consent shall be required for such designation to be effective. 
  
 (b) Such designation of beneficiary may be changed by the participant at any time by written notice. In the event of the death of a
participant and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant’s death, the Company shall deliver such shares and/or cash to the executor or administrator of the estate of the
participant, or if no such executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such shares and/or cash to the spouse or to any one or more dependents or relatives of the
participant, or if no spouse, dependent or relative is known to the Company, then to such other person as the Company may designate. 
  
 16. Transferability. Neither payroll deductions credited to a participant’s account nor any rights with regard to the exercise of an option or
to receive shares under the Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or as provided in Section 15 hereof) by the participant. Any such attempt at
assignment, transfer, pledge or other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds from an Offering Period in accordance with Section 10 hereof. 
  
 17. Use of Funds. All payroll deductions received or held by the
Company under the Plan may be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions. 
  
 18. Reports. Individual accounts shall be maintained for each participant in the Plan. Statements of account shall be given to participating
Employees at least annually, which statements shall set forth the amounts of payroll deductions, the Purchase Price, the number of shares purchased and the remaining cash balance, if any. 
  

 -7- 

 19. Adjustments Upon Changes in Capitalization, Dissolution, Liquidation, Merger or Asset Sale.

  
 (a) Changes in Capitalization. Subject
to any required action by the shareholders of the Company, the Reserves, the maximum number of shares each participant may purchase each Purchase Period (pursuant to Section 7), as well as the price per share and the number of shares of Common Stock
covered by each option under the Plan which has not yet been exercised shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of the Common Stock, or any other increase or decrease in the number of shares of Common Stock effected without receipt of consideration by the Company; provided, however, that conversion of any convertible securities
of the Company shall not be deemed to have been “effected without receipt of consideration.” Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except as expressly
provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares
of Common Stock subject to an option. 
  
 (b)
Dissolution or Liquidation. In the event of the proposed dissolution or liquidation of the Company, the Offering Period then in progress shall be shortened by setting a new Exercise Date (the “New Exercise Date”), and shall
terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the Board. The New Exercise Date shall be before the date of the Company’s proposed dissolution or liquidation. The Board
shall notify each participant in writing, at least ten (10) business days prior to the New Exercise Date, that the Exercise Date for the participant’s option has been changed to the New Exercise Date and that the participant’s option shall
be exercised automatically on the New Exercise Date, unless prior to such date the participant has withdrawn from the Offering Period as provided in Section 10 hereof. 
  
 (c) Merger or Asset Sale. In the event of a proposed sale of all or substantially all of the assets
of the Company, or the merger of the Company with or into another corporation, each outstanding option shall be assumed or an equivalent option substituted by the successor corporation or a Parent or Subsidiary of the successor corporation. In the
event that the successor corporation refuses to assume or substitute for the option, any Purchase Periods then in progress shall be shortened by setting a new Exercise Date (the “New Exercise Date”) and any Offering Periods then in
progress shall end on the New Exercise Date. The New Exercise Date shall be before the date of the Company’s proposed sale or merger. The Board shall notify each participant in writing, at least ten (10) business days prior to the New Exercise
Date, that the Exercise Date for the participant’s option has been changed to the New Exercise Date and that the participant’s option shall be exercised automatically on the New Exercise Date, unless prior to such date the participant has
withdrawn from the Offering Period as provided in Section 10 hereof. 
  
 20. Amendment or Termination. 
  
 (a) The Board of Directors of the Company may at any time and for any reason terminate or amend the Plan. Except as provided in Section 19 hereof, no such termination can affect options previously granted, provided that an Offering Period
may be terminated by the Board 
  

 -8- 

 of Directors on any Exercise Date if the Board determines that the termination of the Offering Period or
the Plan is in the best interests of the Company and its shareholders. Except as provided in Section 19 and this Section 20 hereof, no amendment may make any change in any option theretofore granted which adversely affects the rights of any
participant. To the extent necessary to comply with Section 423 of the Code (or any successor rule or provision or any other applicable law, regulation or stock exchange rule), the Company shall obtain shareholder approval in such a manner and to
such a degree as required. 
  
 (b) Without
shareholder consent and without regard to whether any participant rights may be considered to have been “adversely affected,” the Board (or its committee) shall be entitled to change the Offering Periods, limit the frequency and/or number
of changes in the amount withheld during an Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit payroll withholding in excess of the amount designated by a participant in order
to adjust for delays or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the
purchase of Common Stock for each participant properly correspond with amounts withheld from the participant’s Compensation, and establish such other limitations or procedures as the Board (or its committee) determines in its sole discretion
advisable which are consistent with the Plan. 
  
 (c) In the event the Board determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the Board may, in its discretion and, to the extent necessary or desirable, modify or amend the Plan
to reduce or eliminate such accounting consequence including, but not limited to: 
  
 (i) altering the Purchase Price for any Offering Period including an Offering Period underway at the time of the change in Purchase Price;

  
 (ii) shortening any Offering Period so that
Offering Period ends on a new Exercise Date, including an Offering Period underway at the time of the Board action; and 
  
 (iii) allocating shares. 
  
 Such modifications or amendments shall not require stockholder approval or the consent of any Plan participants. 
  
 21. Notices. All notices or other communications by a participant to
the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof. 
  
 22. Conditions Upon Issuance of Shares. Shares shall not be issued
with respect to an option unless the exercise of such option and the issuance and delivery of such shares pursuant thereto shall comply with all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of
1933, as amended, the Securities Exchange Act of 1934, as amended, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the shares may then be listed, and shall be further subject to the approval of
counsel for the Company with respect to such compliance. 
  

 -9- 

 As a condition to the exercise of an option, the Company may require the person
exercising such option to represent and warrant at the time of any such exercise that the shares are being purchased only for investment and without any present intention to sell or distribute such shares if, in the opinion of counsel for the
Company, such a representation is required by any of the aforementioned applicable provisions of law. 
  
 23. Term of Plan. The Plan shall become effective upon the earlier to occur of its adoption by the Board of Directors or its approval by the
shareholders of the Company. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 20 hereof. 
  
 24. Automatic Transfer to Low Price Offering Period. To the extent permitted by any applicable laws, regulations, or stock exchange rules if the
Fair Market Value of the Common Stock on any Exercise Date in an Offering Period is lower than the Fair Market Value of the Common Stock on the Enrollment Date of such Offering Period, then all participants in such Offering Period shall be
automatically withdrawn from such Offering Period immediately after the exercise of their option on such Exercise Date and automatically re-enrolled in the immediately following Offering Period. 
  

 -10- 

 EXHIBIT A 
  
 SIRENZA MICRODEVICES, INC. 
  

2000 EMPLOYEE STOCK PURCHASE PLAN 
  
 SUBSCRIPTION AGREEMENT 
  

			
	             Original Application	 	Enrollment Date:
                            
	             Change in Payroll Deduction Rate	 	Purchase Period:
                                        
                    
	             Change of Beneficiary(ies)	 	 

  

	1.	                                      
                           (PRINT NAME) hereby elects to participate in the Sirenza Microdevices, Inc. Employee
Stock Purchase Plan (the “Employee Stock Purchase Plan”) and subscribes to purchase shares of the Company’s Common Stock in accordance with this Subscription Agreement and the Employee Stock Purchase Plan. 

  

	2.	I hereby authorize payroll deductions from each paycheck in the amount of             % of my Compensation on each
payday (from 0 to 15%) during the Offering Period in accordance with the Employee Stock Purchase Plan. (Please note that no fractional percentages are permitted.) 

  

	3.	I understand that said payroll deductions shall be accumulated for the purchase of shares of Common Stock at the applicable Purchase Price determined in accordance with the Employee
Stock Purchase Plan. I understand that if I do not withdraw from an Offering Period, any accumulated payroll deductions will be used to automatically exercise my option. 

  

	4.	I have received a copy of the complete Employee Stock Purchase Plan. I understand that my participation in the Employee Stock Purchase Plan is in all respects subject to the terms
of the Plan. I understand that my ability to exercise the option under this Subscription Agreement is subject to shareholder approval of the Employee Stock Purchase Plan. 

  

	5.	Shares purchased for me under the Employee Stock Purchase Plan should be issued in the name(s) of (Employee or Employee and Spouse only). 

  

	6.	I understand that if I dispose of any shares received by me pursuant to the Plan within 2 years after the Enrollment Date (the first day of the Offering Period during which I
purchased such shares) or one year after the Exercise Date, I will be treated for federal income tax purposes as having received ordinary income at the time of such disposition in an amount equal to the excess of the fair market value of the shares
at the time such shares were purchased by me over the price which I paid for the shares. I hereby agree to notify the Company in writing within 30 days after the date of any disposition of my shares and I will make adequate provision for Federal,
state or other tax withholding obligations, if any, which arise upon the 

 disposition of the Common Stock. The Company may, but will not be obligated to, withhold from my
compensation the amount necessary to meet any applicable withholding obligation including any withholding necessary to make available to the Company any tax deductions or benefits attributable to sale or early disposition of Common Stock by me. If I
dispose of such shares at any time after the expiration of the 2-year and 1-year holding periods, I understand that I will be treated for federal income tax purposes as having received income only at the time of such disposition, and that such
income will be taxed as ordinary income only to the extent of an amount equal to the lesser of (1) the excess of the fair market value of the shares at the time of such disposition over the purchase price which I paid for the shares, or (2) 15% of
the fair market value of the shares on the first day of the Offering Period. The remainder of the gain, if any, recognized on such disposition will be taxed as capital gain. 
  

	7.	I hereby agree to be bound by the terms of the Employee Stock Purchase Plan. The effectiveness of this Subscription Agreement is dependent upon my eligibility to participate in the
Employee Stock Purchase Plan. 

  

	8.	In the event of my death, I hereby designate the following as my beneficiary(ies) to receive all payments and shares due me under the Employee Stock Purchase Plan:

  

					
	BENEFICIARY NAME: (Please print)	  	 	  	 
	  

	(First)	  	(Middle)	  	(Last)
		
	  

	  	

	Relationship	  	  

	 	  	 (Address)

  

 -2- 

			
	Employee’s Social Security Number:	 	  

		
	 Employee’s Address:
	 	  

		
	 	 	  

		
	 	 	  

  
 I UNDERSTAND THAT THIS SUBSCRIPTION
AGREEMENT SHALL REMAIN IN EFFECT THROUGHOUT SUCCESSIVE OFFERING PERIODS UNLESS TERMINATED BY ME. 
  

					
	 Dated:
	 	  

	  	  

	 	 	 	  	 Signature of Employee

			
	 	 	 	  	  

	 	 	 	  	 Spouse’s Signature (If beneficiary other than spouse)

  

 -3- 

 EXHIBIT B 
  
 SIRENZA MICRODEVICES, INC. 
  
 2000 EMPLOYEE STOCK PURCHASE PLAN 
  
 NOTICE OF WITHDRAWAL 
  
 The undersigned participant in the Offering Period of the Sirenza Microdevices, Inc. Employee Stock Purchase Plan which began on
                    ,              (the “Enrollment Date”) hereby
notifies the Company that he or she hereby withdraws from the Offering Period. He or she hereby directs the Company to pay to the undersigned as promptly as practicable all the payroll deductions credited to his or her account with respect to such
Offering Period. The undersigned understands and agrees that his or her option for such Offering Period will be automatically terminated. The undersigned understands further that no further payroll deductions will be made for the purchase of shares
in the current Offering Period and the undersigned shall be eligible to participate in succeeding Offering Periods only by delivering to the Company a new Subscription Agreement. 
  

			
	 Name and Address of Participant:

	  

	  

	  

	
	 Signature:

	  

	 Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]